Submit RFP

X Close
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Diagnostics and therapeutics

Innovations are powering earlier diagnoses, personalised treatment and better surgical outcomes.

Companies already investing in
this opportunity

Merck Millipore ● Gatorade ● Philips BioTelemetry ● Epicore Biosystems ● Zühlke ● Miroculus ● Breathonix 25CF

Investment opportunities in diagnostics and therapeutics to 2030

Developments in diagnostics and therapeutics are paving the way for a revolution in everything from at-home genetic testing to creams for drug delivery. We expect to see opportunities across digital surgery technologies, rapid diagnostics market and personalised medicine in the years to come.

Five promising use cases in

Diagnostics and therapeutics

  1. Rapid home-based diagnostics through easily-accessible low-cost antigen, lateral flow, and isothermal amplification tests.
  2. Computer vision-based deep learning and processing of medical imaging for new possibilities for AI diagnostics & interpretation.
  3. Skin health biosensors/medical dermal patches monitoring skin condition or delivering a medication or supplement into the skin.
  4. Augmented/ virtual reality systems for surgeries and surgical navigation.
  5. Disease diagnostics using breath biomarkers via breathalysers, smart inhalers, and electronic noses.

What are the opportunities in diagnostics and therapeutics?

Diagnostics and therapeutics are transitioning from the “one-size-fits-all” approach. Reductions in the cost of diagnostics and better use of algorithms to develop personalised plans are enabling bespoke solutions. Personalised medicine and therapeutics have long been touted as the future of healthcare. The sector, which is already worth over $2.12 trillion, is projected to reach $5.7 trillion by 2030.  

Furthermore, the market for digital surgery technologies, which includes robotics, artificial intelligence (AI), advanced imaging, and connected devices, is projected to grow at an average annual growth rate of over 32 percent. Examples of digital surgery technologies include augmented reality navigation headsets allowing doctors to visualise patients’ 3D anatomy during surgery in real-time. The global digital surgery technologies market size is projected to grow from $0.50 billion in 2021 to $ 5.21 billion by 2030, an annual growth rate of over 32 percent.

Use Case

What are examples of nanotechnology in diagnostics and therapeutics?

Examples of nanotechnology in diagnostics and therapeutics include slow-release drug capsules enabled by new pill coatings. Nanotechnology also enables more targeted drugs covered with specific coatings that bind tighter to the affected site, reducing its negative impact on other parts of the body.


Growth in rapid diagnostics to 2029


Opportunities in personalised medicine sector to 2030


Annual growth rate in digital surgery technologies to 2030.

What are examples of leading companies in this sector?

Technology, media, telecom and electronics have been pioneering in areas such as deploying augmented reality for surgeries and surgical navigation. In personalised treatment, Philips BioTelemetry offers cardiac monitoring medical devices, such as Mobile Cardiac Outpatient Telemetry (MCOT) and Philips BioTel Heart, which is a provider of remote cardiac monitoring diagnostic services.

Epicore Biosystems, in partnership with PepsiCo and Gatorade, has developed the Gx Sweat Patch, a skin-like, wearable microfluidic sensing patch designed to capture sweat and offer real-time insights. When paired with a mobile app, it provides personalised recommendations for athletes to optimally hydrate and refuel after exercise.